Hemnet shares fall as Q1 EBITDA drops 43% on weak listings

Hemnet's Q1 results were weak, with net sales down 24.7% to 247.2 million Swedish crowns and adjusted EBITDA falling 43.3% to 89.3 million crowns as the new deferred-payment listing service delayed revenue recognition. Paid listings dropped 38.3% to 25,400, and Citi said April data implies a Q2 run rate of about 36,000 listings versus 41,000 consensus. Management kept long-term targets unchanged, but the earnings miss and weaker-than-expected volumes likely pressure the shares.

Analysis

The core issue is not the headline earnings miss; it is the timing mismatch created by the deferred-payment product. That smooths customer acquisition and may improve conversion, but it also shifts recognized revenue out of the current quarter, which makes near-term growth screens look weaker just as the company is trying to defend its premium valuation. If the sell-through curve stays intact, reported revenue should reaccelerate mechanically over the next 1-2 quarters, but the market will likely penalize any sign that adoption is being used to mask a soft underlying housing cycle.

The second-order risk is that Hemnet is effectively financing sellers’ optionality while taking on a more working-capital-like profile without a balance-sheet offset. Rising net debt alongside lower operating cash flow reduces room for execution errors, especially if listing volumes remain below consensus into summer. The key catalyst is not April alone, but whether the conversion rate of the deferred cohort remains near 60% and whether published listings continue to improve sequentially; if not, the “growth bridge” into the second half breaks and the stock can de-rate further.

There is a possible contrarian read: the weaker quarter may be the cleanest evidence that Hemnet can trade off timing for lifetime monetization without destroying pricing power, since average revenue per paid listing is still rising. If the product improves buyer/seller acquisition and the backlog monetizes, consensus may be underestimating second-half revenue catch-up. But that upside only matters if volume inflects; absent that, the market will focus on the forward listing run rate, not the deferred revenue promise.

Key Decisions for Investors

• Short HEMNET-style exposure via a listed proxy if available; otherwise use a single-name short on Hemnet on any rally toward pre-earnings levels, targeting 6-10% downside over 4-8 weeks if listing volumes stay below the implied run rate.
• Buy near-dated call spreads only after two consecutive monthly published-listing prints show sequential improvement; the setup is high beta to volume recovery, but premature longs are vulnerable to another guidance reset.
• Pair trade: long a high-quality housing transaction platform with steadier recognition and short HEMNET, to isolate product/timing risk from the broader housing cycle; this works best over 1-2 quarters if deferred-revenue accounting keeps suppressing reported growth.
• Watch for a balance-sheet inflection: if net debt/EBITDA moves above ~1.0x without a clear volume rebound, cut long exposure immediately, as leverage will begin to matter more than margin expansion.